AVIR Atea Pharmaceuticals, Inc.: institutional ownership and insider trading
132 funds reported holding $293M of Atea Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net sold $3.48M, with 17 new positions and 20 funds selling out; over the last 12 months insiders bought $25.4K and sold $0 on the open market.
Famous investors holding AVIR
- Two Sigma (Two Sigma Investments): $7.01M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $5.26M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.61M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.42M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $731K, 0.0% of the portfolio
Largest institutional holders of AVIR
- FMR LLC — $55.8M
- BlackRock, Inc. (BLK) — $40.5M
- BML Capital Management, LLC — $32.3M
- TANG CAPITAL MANAGEMENT LLC — $22.4M
- VANGUARD GROUP INC — $15.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $13.8M
- Bain Capital Life Sciences Investors, LLC — $9.65M
- ACADIAN ASSET MANAGEMENT LLC — $9.46M
- GEODE CAPITAL MANAGEMENT, LLC — $9.11M
- STATE STREET CORP (STT, STT-PG) — $7.68M
Recent AVIR insider trades
- May 18, 2026: Murphy Polly A. bought 6,100 shares ($25.4K)
- Jan 16, 2025: Berger Franklin M bought 25,000 shares ($81.5K)
- Dec 10, 2024: Berger Franklin M sold 359,606 shares ($1.02M)
5%+ owners
- FMR LLC: 15.0% (Schedule 13G/A, filed May 6, 2026)
- TANG CAPITAL MANAGEMENT, LLC: 6.0% (Schedule 13G, filed Oct 6, 2026)